Replies to post #6357 on Bioelectronics Corp (BIEL)

[blueone]

Seems to me the problem is a lack of clear communication about important isues and getting shareholder questions answered honestly and directly. That's why Andrew should put out a PR to address the O/S issue, the dilution issue, etc. Granted, they have no control over when the FDA decision comes out.

But its because of lack of clarity on above issues that the heat is rising, (along with the frustrating delays from FDA).

Why should we be bouncing between 7/8 cents if there is so much potential here? How come we couldn't hold the 10-12 cent range at least? People smell shares being dumped, and that needs to be put to rest to restore confidence.

[Ryoko]

I agree there's too many people bombing AW with the same questions over and over again which is why I haven't personally called. Technically, Joe should be handling these kinds of questions, but his answers tend to be vague when and if he does decide to answer. I think AW may have finally gotten tired of the phone calls and gave Joe a nudge.

Regarding some of Joe's answers:

**1) With most of the debt now converted there should be a significant deceleration in dilution.

Yikes! "There should be"??? How many of us got the impression that the debt conversion was complete from earlier comments from Joe?

**12) ...we want to move off of the pink sheets and onto a different stock trading venue. We have specific plans to do this, but it is inappropriate at this time to discuss in detail.

I don't understand this statement. Are they afraid their competitors might learn they are wanting to move off the pinks? I've held other pinks that were planning to move and they couldn't wait to talk about it. It's a significant milestone for a growing company.